Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.
Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.
复制标题
添加一种可改善 HIV 感染患者初始抗逆转录病毒治疗 (ART) 免疫反应的药物的成本效益：药物开发指南。
DOI：
10.1310/hct1301-001
复制
发表时间：
2012
影响因子：
--
通讯作者：
Schackman,BruceR
中科院分区：
文献类型：
--
作者：
Morris,BethanyL;Scott,CallieA;Wilkin,TimothyJ;Sax,PaulE;Gulick,RoyM;Freedberg,KennethA;Schackman,BruceR
